Raymond James Financial Inc Neuronetics, Inc. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Neuronetics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 24,164 shares of STIM stock, worth $47,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,164
Previous 10,577
128.46%
Holding current value
$47,603
Previous $36,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding STIM
# of Institutions
112Shares Held
21.8MCall Options Held
1.58MPut Options Held
213K-
Vanguard Group Inc Valley Forge, PA2.83MShares$5.58 Million0.0% of portfolio
-
Ubs Group Ag2.16MShares$4.26 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.82MShares$3.59 Million0.01% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$3.42 Million1.44% of portfolio
-
Wexford Capital LP Greenwich, CT1.18MShares$2.32 Million0.49% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $53.2M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...